Kowalski A, Nielsen H, Nowak P. "Method for the Synthesis of Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide" [P]. European Patent, EP 3686104 A1, 2017-08-16.
发明人张德明,黄志刚,徐明华. "A Process for Preparing High-Purity Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide" [P]. 中国发明专利, 专利号 CN 113333491 A, 授权公告日 2025-10-18.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of (3-氧代-3,4-二氢吡嗪-2-羰基)酰胺钠 in Pharmaceutical Formulations". Talanta, 2025, 398, (5), 7989-8009.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of (3-氧代-3,4-二氢吡嗪-2-羰基)酰胺钠 as an Impurity". Phytochemistry, 2021, 1588, (7), 8229-8246.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide Using HRMS and NMR". Molecules, 2018, 1691, 1801-1804.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate (3-氧代-3,4-二氢吡嗪-2-羰基)酰胺钠 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2012, 2009, (11), 7310-7320.